Changes in differential gene expression of the lipid metabolism network identified the Parkinson’s risk gene CHCHD2 (PARK 22) as significantly downregulated in the neurons carrying the p.A30P SNCA mutation compared to the gene-corrected isogenic control. The gene discussed is CHCHD2; the disease is Parkinson disease.